BSI PD CEN ISO/TS 16775:2021
$215.11
Packaging for terminally sterilized medical devices. Guidance on the application of ISO 11607-1 and ISO 11607-2
Published By | Publication Date | Number of Pages |
BSI | 2021 | 154 |
This document provides guidance for the application of the requirements contained in ISO 11607-1 and ISO 11607-2 . It does not add to, or otherwise change, the requirements of ISO 11607-1 and ISO 11607-2 . This is an informative document, not normative. It does not include requirements to be used as basis of regulatory inspection or certification assessment activities.
The guidance can be used to better understand the requirements of ISO 11607-1 and ISO 11607-2 and illustrates the variety of methods and approaches available for meeting the requirements of those International Standards. It is not required that this document be used to demonstrate conformity with them.
Guidance is given for evaluation, selection and use of packaging materials, preformed sterile barrier systems, sterile barrier systems and packaging systems. Guidance on validation requirements for forming, sealing and assembly processes is also given.
This document provides information for both healthcare facilities and the medical devices industry for terminally sterilized medical devices.
This document does not provide guidance for applications of packaging materials and systems after their opening. In the use of packaging for other purposes such as a “sterile field” or transport of contaminated items, other regulatory standards will apply.
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | National foreword |
4 | European foreword |
9 | Foreword |
10 | Introduction |
11 | 1 Scope 2 Normative references 3 Terms and definitions |
12 | 4 Guidance on Clauses 1-4 of ISO 11607‑1:2019 and ISO 11607‑2:2019 4.1 Scope (ISO 11607‑1:2019, Clause 1 and ISO 11607‑2:2019, Clause 1) 4.1.1 Intent 4.1.2 Guidance |
13 | 4.2 Normative references (ISO 11607‑1:2019, Clause 2 and ISO 11607‑2:2019, Clause 2) 4.2.1 Intent 4.2.2 Guidance |
14 | 4.3 Terms and definitions (ISO 11607‑1:2019, Clause 3 and ISO 11607‑2:2019, Clause 3) 4.3.1 Intent 4.3.2 Guidance 4.4 Quality and risk management (ISO 11607‑1:2019, 4.1, 4.2 and ISO 11607‑2:2019, 4.1, 4.2) 4.4.1 Intent 4.4.2 Guidance |
16 | 4.5 Sampling (ISO 11607‑1:2019, 4.3 and ISO 11607‑2:2019, 4.3) 4.5.1 Intent 4.5.2 Guidance |
17 | 4.6 Test methods (ISO 11607‑1:2019, 4.4 and ISO 11607‑2:2019, 4.4) 4.6.1 Intent 4.6.2 Guidance |
19 | 4.7 Documentation (ISO 11607‑1:2019, 4.5 and ISO 11607‑2:2019, 4.5) 4.7.1 Intent 4.7.2 Guidance |
20 | 5 Guidance on Clauses 5-11 of ISO 11607‑1:2019 5.1 General requirements for materials, preformed sterile barrier systems and sterile barrier systems (ISO 11607‑1:2019, 5.1.1 and 5.1.2) 5.1.1 Intent 5.1.2 Guidance 5.2 Conditions for production and handling (ISO 11607‑1:2019, 5.1.3 and 5.1.4) 5.2.1 Intent 5.2.2 Guidance |
21 | 5.3 Source, history and traceability of materials (ISO 11607‑1:2019, 5.1.5) 5.3.1 Intent 5.3.2 Guidance |
22 | 5.4 Properties to be evaluated (ISO 11607‑1:2019, 5.1.6) 5.4.1 Intent 5.4.2 Guidance 5.5 General performance requirements for materials (ISO 11607‑1:2019, 5.1.7 and 5.1.8) 5.5.1 Intent |
23 | 5.5.2 Guidance |
26 | 5.6 Additional requirements for sterile barrier systems and preformed sterile barrier systems (ISO 11607‑1:2019, 5.1.9) 5.6.1 Intent 5.6.2 Guidance |
27 | 5.7 Reusable sterile barrier systems (ISO 11607‑1:2019, 5.1.10, 5.1.11 and 5.1.12) 5.7.1 Intent 5.7.2 Guidance 5.8 Microbial barrier properties (ISO 11607‑1:2019, 5.2) 5.8.1 Intent 5.8.2 Guidance |
28 | 5.9 Compatibility with the sterilization process (ISO 11607‑1:2019, 5.3) 5.9.1 Intent 5.9.2 Guidance |
29 | 5.10 Labelling system (ISO 11607‑1:2019, 5.4) 5.10.1 Intent 5.10.2 Guidance |
31 | 5.11 Storage and transport of materials and preformed sterile barrier systems (ISO 11607‑1:2019, 5.5) 5.11.1 Intent 5.11.2 Guidance |
32 | 5.12 Design and development (ISO 11607‑1:2019, 6.1.1) 5.12.1 Intent 5.12.2 Guidance |
33 | 5.13 Aseptic presentation (ISO 11607‑1:2019, 6.1.2) 5.13.1 Intent 5.13.2 Guidance |
34 | 5.14 Physical protection (ISO 11607‑1:2019, 6.1.3 and 6.1.4) 5.14.1 Intent 5.14.2 Guidance |
35 | 5.15 Sterilization compatibility (ISO 11607‑1:2019, 6.1.5) 5.15.1 Intent 5.15.2 Guidance 5.16 Maintenance of Sterility (ISO 11607‑1:2019, 6.1.6 and 6.1.7) 5.16.1 Intent 5.16.2 Guidance |
36 | 5.17 Requirements for multi-layer packaging (ISO 11607‑1:2019, 6.1.8) 5.17.1 Intent 5.17.2 Guidance |
37 | 5.18 Packaging families (ISO 11607‑1:2019, 6.1.9) 5.18.1 Intent 5.18.2 Guidance |
38 | 5.19 Design process (ISO 11607‑1:2019, 6.2.1) 5.19.1 Intent |
39 | 5.19.2 Guidance 5.20 Design inputs (ISO 11607‑1:2019, 6.2.2 and 6.2.3) 5.20.1 Intent 5.20.2 Guidance |
41 | 5.21 Sterile fluid path (ISO 11607‑1:2019, 6.2.4, 6.2.5) 5.21.1 Intent 5.21.2 Guidance |
42 | 5.22 Usability evaluation for aseptic presentation (ISO 11607‑1:2019, 7.1, 7.2 and 7.3) 5.22.1 Intent 5.22.2 Guidance |
43 | 5.23 Leveraging usability evaluations (ISO 11607‑1:2019, 7.4) 5.23.1 Intent 5.23.2 Guidance 5.24 Usability evaluation failures (ISO 11607‑1:2019, 7.5) 5.24.1 Intent 5.24.2 Guidance |
44 | 5.24.3 Guidance on formative and summative studies |
45 | 5.25 Packaging system performance and stability (ISO 11607‑1:2019, 8.1) 5.25.1 Intent 5.25.2 Guidance |
47 | 5.26 Packaging system performance testing (ISO 11607‑1:2019, 8.2) 5.26.1 Intent 5.26.2 Guidance |
48 | 5.27 Stability testing (ISO 11607‑1:2019, 8.3) 5.27.1 Intent 5.27.2 Guidance |
50 | 5.28 Packaging system validation and changes (ISO 11607‑1:2019, 9.1) 5.28.1 Intent 5.28.2 Guidance 5.29 Change control (ISO 11607‑1:2019, 9.2) 5.29.1 Intent 5.29.2 Guidance 5.30 Revalidations (ISO 11607‑1:2019, 9.3, 9.4, and 9.5) 5.30.1 Intent 5.30.2 Guidance |
51 | 5.31 Inspection immediately prior to aseptic presentation (ISO 11607‑1:2019, Clause 10) 5.31.1 Intent 5.31.2 Guidance 5.32 Information to be provided (ISO 11607‑1:2019, Clause 11) 5.32.1 Intent 5.32.2 Guidance |
52 | 6 Guidance on Clauses 5-8 of ISO 11607‑2:2019 6.1 General Clauses 1-4 of ISO 11607‑2:2019 6.2 Validation of packaging processes – general requirements (ISO 11607‑2:2019, 5.1.1 and 5.1.2) 6.2.1 Intent 6.2.2 Guidance |
53 | 6.3 Process specification (ISO 11607‑2:2019, 5.1.3) 6.3.1 Intent 6.3.2 Guidance 6.4 Process validation of packaging families (ISO 11607‑2:2019, 5.1.4) 6.4.1 Intent 6.4.2 Guidance |
54 | 6.5 Installation qualification (ISO 11607‑2:2019, 5.2) 6.5.1 Intent |
55 | 6.5.2 Guidance 6.6 Operational qualification (ISO 11607‑2:2019, 5.3) 6.6.1 Intent |
56 | 6.6.2 Guidance 6.7 Performance qualification (ISO 11607‑2:2019, 5.4) 6.7.1 Intent 6.7.2 Guidance |
57 | 6.8 Formal approval of the process validation (ISO 11607‑2:2019, 5.5) 6.8.1 Intent 6.8.2 Guidance |
58 | 6.9 Process control and monitoring (ISO 11607‑2:2019, 5.6) 6.9.1 Intent 6.9.2 Guidance 6.10 Process changes and revalidation (ISO 11607‑2:2019, 5.7) 6.10.1 Intent 6.10.2 Guidance |
59 | 6.11 Assembly (ISO 11607‑2:2019, Clause 6) 6.11.1 Intent 6.11.2 Guidance |
61 | 6.12 Use of reusable sterile barrier systems (ISO 11607‑2:2019, Clause 7) 6.12.1 Intent 6.12.2 Guidance 6.13 Sterile fluid path packaging (ISO 11607‑2:2019, Clause 8) 6.13.1 Intent 6.13.2 Guidance |
62 | Bibliography |
67 | Annex A (informative) Design and development for packaging systems – guidance for industry |
75 | Annex B (informative) Guidance on the application of the ISO 11607 series in healthcare facilities |
106 | Annex C (informative) Risk analysis tools — Guidance for industry and healthcare facilities |
108 | Annex D (informative) Considerations for sampling plans – Guidance for healthcare facilities |
110 | Annex E (informative) Guidance on establishing process parameters – guidance for industry |
116 | Annex F (informative) Sterilization considerations – Guidance for industry and healthcare facilities |
123 | Annex G (informative) Use of contract packagers – Guidance for industry and healthcare facilities |
124 | Annex H (informative) Example of a handling, distribution and storage checklist – Guidance for healthcare facilities for selecting a sterile barrier system |
126 | Annex I (informative) Investigating failure – Guidance for industry and healthcare facilities |
130 | Annex J (informative) Validation summary – Guidance for healthcare facilities |
132 | Annex K (informative) Validation for wrapping process — Guidance for healthcare facilities |
138 | Annex L (informative) Validation for reusable container process – Guidance for healthcare facilities |
144 | Annex M (informative) Validation for heat sealing process for preformed sterile barrier systems (PSBS) – Guidance for healthcare facilities |